Mandavi Kulkarni, MD
Infectious Disease · Michigan City, INNPI 1770512659
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,013 and has fallen 97.9% since, to $43 in 2025.
Across 217 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$520
- AbbVie$480
- Gilead$414
- Merck$289
- Johnson & Johnson$195
- Paratek Pharmaceuticals, Inc.$191
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$361%
- Food & beverage$3,40392%
- Education$2767%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 32 | $520 |
| AbbVie(2 entities) | 22 | $480 |
| Gilead | 29 | $414 |
| Merck | 21 | $289 |
| Johnson & Johnson | 12 | $195 |
| Paratek Pharmaceuticals, Inc. | 12 | $191 |
| Astellas Pharma US Inc | 7 | $152 |
| Tetraphase Pharmaceuticals, Inc. | 10 | $151 |
| Insmed, Inc. | 4 | $141 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $141 |
| Melinta Therapeutics, LLC | 6 | $101 |
| Theratechnologies Inc. | 6 | $100 |
| Janssen Products, LP | 1 | $99 |
| Napo Pharmaceuticals Inc | 6 | $90 |
| Shionogi Inc | 3 | $56 |
| Mylan Specialty L.p. | 3 | $52 |
| Smith+Nephew | 4 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Mayne Pharma Commercial LLC | 3 | $45 |
| Cumberland Pharmaceuticals, Inc. | 3 | $38 |
| Ironwood Pharmaceuticals, Inc | 2 | $36 |
| AstraZeneca | 2 | $34 |
| Nabriva Therapeutics, PLC | 2 | $32 |
| Convatec Inc. | 2 | $29 |
| Shire North American Group Inc | 2 | $27 |
| Bio Products Laboratory USA, Inc. | 1 | $27 |
| Pfizer | 2 | $26 |
| Aroa Biosurgery Incorporated | 2 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Philips North America LLC | 1 | $22 |
| Novo Nordisk | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $19 |
| CSL Behring | 1 | $15 |
| Hospira, Inc. | 1 | $15 |
| La Jolla Pharmaceutical Company | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOVATO$125
How this compares
$3,715 in reported general payments places this provider in the 85th percentile of 152 infectious disease providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Michigan City
- Timothy FransonZionsville$303K
- Donald TherasseZionsville$75K
- Anwer JaffriTerre Haute$63K
- Jason BaileyFort Wayne$60K
- Markian BochanCarmel$54K
- Samir GuptaIndianapolis$53K
- Erica Kaufman WestDyer$48K
- Tracey IkerdCarmel$39K
- Darron BrownIndianapolis$21K
- Imad KojTerre Haute$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.